Singapore Medical Group has its heart set on regional growth
The group aims to strengthen its foothold abroad, albeit with cautious optimism, especially in Australia, Vietnam and Indonesia.
OPPORTUNITIES abound beyond Singapore's shores, and specialist healthcare provider Singapore Medical Group (SMG) is raring to go.
Even as it continues to grow its domestic business across the Republic's heartlands, the Catalist-listed company is hungry for further expansion and new ventures in the Asia-Pacific.
"We're one of the few Singapore healthcare companies that have been actively investing and growing our overseas footprint. From that standpoint, we're extremely unique," says Beng Teck Liang, SMG's chief executive officer and executive director.
TRENDING NOW
The S$1 million National Day paradox: ‘money dysmorphia’ amid a wealth surge
CapitaLand Investment to restructure portfolio, recycle up to S$9 billion
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry